# Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC (Text with EEA relevance), Division 55

Extent: E+W+S+N.I.

Without prejudice to Article 65, the documentation requirements set out in sections F and G shall also apply to auxiliary medicinal products. However, where the auxiliary medicinal product is authorised in the Member State concerned, no additional information is required.

---
Source: https://www.legislation.gov.uk/eur/2014/536/annex/I/division/H/division/55 (the official version)
Page: https://openlegislation.uk/eu-regulation-2014-536/annex-I/division-H/division-55
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.